Filing Details
LIFECORE BIOMEDICAL, INC. \DE\ (NASDAQ:LFCR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 05, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:LFCR
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Files Quarterly Report for Q0
Filing Details LIFECORE BIOMEDICAL, INC. \DE\ (NASDAQ:LFCR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 05, 2026. The Healthcare…
Market Context
LIFECORE BIOMEDICAL, INC. \DE\'s stock currently trades at $4.44 with a market capitalization of $292.2M.
The 10-Q provides LIFECORE BIOMEDICAL, INC. \DE\'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for LIFECORE BIOMEDICAL, INC. \DE\ are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LFCR Stock Page
Frequently Asked Questions
Where can I read LFCR's SEC filings?
Browse all filings on our LFCR SEC filings page.
What types of SEC filings does LIFECORE BIOMEDICAL, INC. \DE\ file?
Public companies like LIFECORE BIOMEDICAL, INC. \DE\ file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.